Cargando…
Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience
SIMPLE SUMMARY: Biliary tract cancer is the second most common type of liver cancer. Patients often present when the disease has spread from the liver to other neighboring or distant parts of the body. Chemotherapy with the combination of gemcitabine and cisplatin has been the standard of care for t...
Autores principales: | Müller, Christian, Omari, Jazan, Mohnike, Konrad, Bär, Caroline, Pech, Maciej, Keitel, Verena, Venerito, Marino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177261/ https://www.ncbi.nlm.nih.gov/pubmed/37174064 http://dx.doi.org/10.3390/cancers15092598 |
Ejemplares similares
-
Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines
por: Sakamoto, Yasunari, et al.
Publicado: (2019) -
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
por: Fiteni, Frédéric, et al.
Publicado: (2014) -
Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space
por: Heinze, Constanze, et al.
Publicado: (2019) -
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
por: Park, Joon Oh, et al.
Publicado: (2015) -
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
por: Inoue, Hiroto, et al.
Publicado: (2021)